Lower-dose thalidomide therapy effectively treats cutaneous lupus erythematosus but is limited by neuropathic toxicity

Int J Dermatol. 2013 Nov;52(11):1407-9. doi: 10.1111/j.1365-4632.2011.05200.x.

¹ Department of Dermatology and Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USADepartment of Dermatology, University of California Davis, Sacramento, CA, USADepartment of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USADepartment of Dermatology and Department of Rheumatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USADepartment of Dermatology and Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

No abstract available

Publication types